Oxidative stress and NAD + in ischemic brain injury: Current advances and future perspectives

Current Medicinal Chemistry

Volumn 17, Issue 20, 2010, Pages 2152-2158

  Ying, W ^a,b   Xiong, Z G ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Robert S Dow Neurobiology Laboratories   (United States)

Author keywords

Brain ischemia; Cell death; Nad +; Oxidative stress; Poly(ADP ribose) polymerase 1; Sirtuins

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SIRTUIN; TISSUE PLASMINOGEN ACTIVATOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL FEATURE; HUMAN; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; REPERFUSION INJURY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; ANIMAL; FEMALE; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; NAD; NADPH OXIDASE; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; SIRTUINS;

EID: 77955601280     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791299911     Document Type: Article

References (102)

1. Davalos, A. Thrombolysis in acute ischemic stroke: successes, failures, and new hopes. Cerebrovasc. Dis., 2005, 20 Suppl 2, 135-139.
2. Lee, J.M.; Zipfel, G.J.; Choi, D.W. The changing landscape of ischaemic brain injury mechanisms. Nature, 1999, 399, A7-14.
3. Chan, P.H. Role of oxidants in ischemic brain damage. Stroke, 1996, 27, 1124-1129.
4. Kristian, T.; Siesjo, B.K. Calcium in ischemic cell death. Stroke, 1998, 29, 705-718.
5. Soane, L.; Kahraman, S.; Kristian, T.; Fiskum, G. Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. J. Neurosci. Res., 2007, 85, 3407-15.
6. Xia, W.; Han, J.; Huang, G.; Ying, W. Inflammation in Ischemic Brain Injury: Current Advances and Future Perspectives. Clin. Exp. Pharmacol. Physiol., 2010, 37, 253-8.
7. Chan, P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab., 2001, 21, 2-14.
8. Ying, W. Deleterious network hypothesis of aging. Med. Hypotheses, 1997, 48, 143-148.
9. Wolozin, B.; Golts, N. Iron and Parkinson's disease. Neuroscientist, 2002, 8, 22-32.
10. Beal, M.F. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J. Bioenerg. Biomembr., 2004, 36, 381-386.
11. Ying, W. A new hypothesis of neurodegenerative diseases: the deleterious network hypothesis. Med. Hypotheses, 1996, 47, 307-313.
12. Moreira, P.I.; Honda, K.; Liu, Q.; Santos, M.S.; Oliveira, C.R.; Aliev, G.; Nunomura, A.; Zhu, X.; Smith, M.A.; Perry, G. Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr. Alzheimer Res., 2005, 2, 403-408.
13. Zhu, X.; Raina, A.K.; Lee, H.G.; Casadesus, G.; Smith, M.A.; Perry, G. Oxidative stress signaling in Alzheimer's disease. Brain Res., 2004, 1000, 32-39.
14. Mhatre, M.; Floyd, R.A.; Hensley, K. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J. Alzheimers Dis., 2004, 6, 147-157.
15. Keller, J.N.; Guo, Q.; Holtsberg, F.W.; Bruce-Keller, A.J.; Mattson, M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci., 1998, 18, 4439-4450.
16. + and NADH in brain functions, brain diseases and brain aging. Front. Biosci., 2007, 12, 1863-1888.
17. Virag, L.; Szabo, C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev., 2002, 54, 375-429.
18. Eliasson, M.J.; Sampei, K.; Mandir, A.S.; Hurn, P.D.; Traystman, R.J.; Bao, J.; Pieper, A.; Wang, Z.Q.; Dawson, T.M.; Snyder, S.H.; Dawson, V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med., 1997, 3, 1089-1095.
19. Endres, M.; Wang, Z.Q.; Namura, S.; Waeber, C.; Moskowitz, M.A. Ischemic brain injury is mediated by the activation of poly(ADP- ribose)polymerase. J. Cereb. Blood Flow Metab., 1997, 17, 1143-1151.
20. Ying, W.; Garnier, P.; Swanson, R.A. NAD repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochem. Biophys. Res. Commun., 2003, 308, 809-813.
21. + depletion and mitochondrial permeability transition. J.Biol.Chem., 2004, 279, 18895-18902.
22. Wang, S.; Xing, Z.; Vosler, P.S.; Yin, H.; Li, W.; Zhang, F.; Signore, A.P.; Stetler, R.A.; Gao, Y.; Chen, J. Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair. Stroke, 2008, 39, 2587-2595.
23. + profoundly decreases brain injury in a rat model of transient focal ischemia. Front. Biosci., 2007, 12, 2728-2734.
24. Turrens, J.F.; Freeman, B.A.; Levitt, J.G.; Crapo, J.D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys., 1982, 217, 401-410.
25. Rashba-Step, J.; Turro, N.J.; Cederbaum, A.I. Increased NADPHand NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch. Biochem. Biophys., 1993, 300, 401-408.
26. Fridovich, I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J. Biol. Chem., 1970, 245, 4053-4057.
27. Rosen, G.M.; Freeman, B.A. Detection of superoxide generated by endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 1984, 81, 7269-7273.
28. Fridovich, I. Superoxide dismutases. Annu. Rev. Biochem., 1975, 44, 147-159.
29. Sims, N.R.; Zaidan, E. Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. Int. J. Biochem. Cell Biol., 1995, 27, 531-550.
30. Beckman, J.S. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol., 1991, 15, 53-59.
31. Marletta, M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell, 1994, 78, 927-930.
32. Griffith, O.W.; Stuehr, D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol., 1995, 57, 707-736.
33. Chen, Y.; Swanson, R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab., 2003, 23, 137-149.
34. Xiong, Z.G.; Zhu, X.M.; Chu, X.P.; Minami, M.; Hey, J.; Wei, W.L.; MacDonald, J.F.; Wemmie, J.A.; Price, M.P.; Welsh, M.J.; Simon, R.P. Neuroprotection in ischemia: blocking calciumpermeable acid-sensing ion channels. Cell, 2004, 118, 687-698.
35. Ying, W.; Han, S.K.; Miller, J.W.; Swanson, R.A. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J.Neurochem., 1999, 73, 1549-1556.
36. Choi, D.W. Excitotoxic cell death. J.Neurobiol., 1992, 23, 1261-1276.
37. Chen, H.; Song, Y.S.; Chan, P.H. Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow Metab., 2009, 29, 1262-1272.
38. Willmot, M.; Gibson, C.; Gray, L.; Murphy, S.; Bath, P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med., 2005, 39, 412-425.
39. Muralikrishna Adibhatla, R.; Hatcher, J.F. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med., 2006, 40, 376-387.
40. Bedard, K.; Krause, K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev., 2007, 87, 245-313.
41. Ushio-Fukai, M. Localizing NADPH oxidase-derived ROS. Sci. STKE, 2006, 2006, re8.
42. Kim, Y.H.; Koh, J.Y. The role of NADPH oxidase and neuronal nitric oxide synthase in zinc- induced poly(ADP-ribose) polymerase activation and cell death in cortical culture. Exp. Neurol., 2002, 177, 407-418.
43. Abramov, A.Y.; Canevari, L.; Duchen, M.R. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci., 2004, 24, 565-575.
44. Abramov, A.Y.; Scorziello, A.; Duchen, M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci., 2007, 27, 1129-1138.
45. Brennan, A.M.; Suh, S.W.; Won, S.J.; Narasimhan, P.; Kauppinen, T.M.; Lee, H.; Edling, Y.; Chan, P.H.; Swanson, R.A. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci., 2009, 12, 857-863.
46. Tang, L.L.; Ye, K.; Yang, X.F.; Zheng, J.S. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J. Int. Med. Res., 2007, 35, 517-522.
47. Kahles, T.; Luedike, P.; Endres, M.; Galla, H.J.; Steinmetz, H.; Busse, R.; Neumann-Haefelin, T.; Brandes, R.P. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke, 2007, 38, 3000-3006.
48. Kim, G.S.; Jung, J.E.; Niizuma, K.; Chan, P.H. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. J. Neurosci., 2009, 29, 14779-14789.
49. Zhang, Q.G.; Raz, L.; Wang, R.; Han, D.; De Sevilla, L.; Yang, F.; Vadlamudi, R.K.; Brann, D.W. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J. Neurosci., 2009, 29, 13823-13836.
50. Inoguchi, T.; Nawata, H. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr. Drug Targets, 2005, 6, 495-501.
51. Zhang, J.; Dawson, V.L.; Dawson, T.M.; Snyder, S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science, 1994, 263, 687-689.
52. Tokime, T.; Nozaki, K.; Sugino, T.; Kikuchi, H.; Hashimoto, N.; Ueda, K. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. J. Cereb. Blood Flow Metab., 1998, 18, 991-997.
53. Love, S.; Barber, R.; Wilcock, G.K. Neuronal accumulation of poly(ADP-ribose) after brain ischaemia. Neuropathol. Appl. Neurobiol., 1999, 25, 98-103.
54. Kauppinen, T.M.; Suh, S.W.; Berman, A.E.; Hamby, A.M.; Swanson, R.A. Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J. Cereb. Blood Flow Metab., 2009, 29, 820-829.
55. Wang, Q.; Tang, X.N.; Yenari, M.A. The inflammatory response in stroke. J. Neuroimmunol., 2007, 184, 53-68.
56. D'Amours, D.; Desnoyers, S.; D'Silva, I.; Poirier, G.G. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem. J., 1999, 342 (Pt 2), 249-268.
57. Chan, P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab., 2001, 21, 2-14.
58. Homburg, S.; Visochek, L.; Moran, N.; Dantzer, F.; Priel, E.; Asculai, E.; Schwartz, D.; Rotter, V.; Dekel, N.; Cohen-Armon, M. A fast signal-induced activation of Poly(ADP-ribose) polymerase: a novel downstream target of phospholipase c. J. Cell Biol., 2000, 150, 293-307.
59. Liu, J.; Ying, W.; Massa, S.; Duriez, P.J.; Swanson, R.A.; Poirier, G.G.; Sharp, F.R. Effects of transient global ischemia and kainate on poly(ADP-ribose) polymerase (PARP) gene expression and proteolytic cleavage in gerbil and rat brains. Brain Res. Mol. Brain Res., 2000, 80, 7-16.
60. Narasimhan, P.; Fujimura, M.; Noshita, N.; Chan, P.H. Role of superoxide in poly(ADP-ribose) polymerase upregulation after transient cerebral ischemia. Brain Res. Mol. Brain Res., 2003, 113, 28-36.
61. Hagberg, H.; Wilson, M.A.; Matsushita, H.; Zhu, C.; Lange, M.; Gustavsson, M.; Poitras, M.F.; Dawson, T.M.; Dawson, V.L.; Northington, F.; Johnston, M.V. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J. Neurochem., 2004, 90, 1068-1075.
62. McCullough, L.D.; Zeng, Z.; Blizzard, K.K.; Debchoudhury, I.; Hurn, P.D. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J. Cereb. Blood Flow Metab., 2005, 25, 502-512.
63. Yuan, M.; Siegel, C.; Zeng, Z.; Li, J.; Liu, F.; McCullough, L.D. Sex differences in the response to activation of the poly (ADPribose) polymerase pathway after experimental stroke. Exp. Neurol., 2009, 217, 210-218.
64. Vagnerova, K.; Liu, K.; Ardeshiri, A.; Cheng, J.; Murphy, S.J.; Hurn, P.D.; Herson, P.S. Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway--do androgens matter? Neuroscience, 166, 476-481.
65. Mabley, J.G.; Horvath, E.M.; Murthy, K.G.; Zsengeller, Z.; Vaslin, A.; Benko, R.; Kollai, M.; Szabo, C. Gender differences in the endotoxin- induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J. Pharmacol. Exp. Ther., 2005, 315, 812-820.
66. Nagayama, T.; Simon, R.P.; Chen, D.; Henshall, D.C.; Pei, W.; Stetler, R.A.; Chen, J. Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia. J. Neurochem., 2000, 74, 1636-1645.
67. + depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J. Neurosci., 30, 2967-2978.
68. Kauppinen, T.M.; Chan, W.Y.; Suh, S.W.; Wiggins, A.K.; Huang, E.J.; Swanson, R.A. Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc. Natl. Acad. Sci. U.S.A., 2006, 103, 7136-7141.
69. Cohen-Armon, M.; Visochek, L.; Rozensal, D.; Kalal, A.; Geistrikh, I.; Klein, R.; Bendetz-Nezer, S.; Yao, Z.; Seger, R. DNAindependent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol. Cell, 2007, 25, 297-308.
70. Xu, Y.; Huang, S.; Liu, Z.G.; Han, J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J. Biol. Chem., 2006, 281, 8788-8795.
71. Zhang, S.; Lin, Y.; Kim, Y.S.; Hande, M.P.; Liu, Z.G.; Shen, H.M. c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ., 2007, 14, 1001-10.
72. Alano, C.C.; Swanson, R.A. Players in the PARP-1 cell-death pathway: JNK1 joins the cast. Trends Biochem. Sci., 2006, 31, 309-311.
73. Fonfria, E.; Marshall, I.C.; Benham, C.D.; Boyfield, I.; Brown, J.D.; Hill, K.; Hughes, J.P.; Skaper, S.D.; McNulty, S. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol., 2004, 143, 186-192.
74. Yang, K.T.; Chang, W.L.; Yang, P.C.; Chien, C.L.; Lai, M.S.; Su, M.J.; Wu, M.L. Activation of the transient receptor potential M2 channel and poly(ADP-ribose) polymerase is involved in oxidative stress-induced cardiomyocyte death. Cell Death Differ., 2005, 13, 1815-26.
75. Fonfria, E.; Marshall, I.C.; Boyfield, I.; Skaper, S.D.; Hughes, J.P.; Owen, D.E.; Zhang, W.; Miller, B.A.; Benham, C.D.; McNulty, S. Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J. Neurochem., 2005, 95, 715-723.
76. Andrabi, S.A.; Kim, N.S.; Yu, S.W.; Wang, H.; Koh, D.W.; Sasaki, M.; Klaus, J.A.; Otsuka, T.; Zhang, Z.; Koehler, R.C.; Hurn, P.D.; Poirier, G.G.; Dawson, V.L.; Dawson, T.M. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl. Acad. Sci. U.S.A., 2006, 103, 18308-18313.
77. Yu, S.W.; Andrabi, S.A.; Wang, H.; Kim, N.S.; Poirier, G.G.; Dawson, T.M.; Dawson, V.L. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. U S A, 2006, 103, 18314-18319.
78. Cai, A.L.; Zipfel, G.J.; Sheline, C.T. Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway. Eur. J. Neurosci., 2006, 24, 2169-2176.
79. Araki, T.; Sasaki, Y.; Milbrandt, J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 2004, 305, 1010-1013.
80. + depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem., 2005, 280, 43121-43130.
81. + and NADH in cellular functions and cell death. Front. Biosci., 2006, 11, 3129-3148.
82. +/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal, 2008, 10, 179-206.
83. + profoundly decreases brain injury in a rat model of transient focal ischemia. Front Biosci., 2007, 12, 2728-2734.
84. + administration can profoundly decrease the brain injury induced by hypoxia-ischemia. FASEB J., In Press, 2010 Experimental Biology Conference Abstracts.
85. + synthesis in cardiac myocytes. Circ. Res., 2009, 105, 481-491.
86. + for treating neurological diseases. Future Neurology, 2007, 2, 1-4.
87. + induces C6 glioma cell death by generating oxidative stress and increasing intracellular calcium concentrations. FASEB J., In Press, 2010 Experimental Biology Conference Abstracts.
88. Guarente, L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev., 2000, 14, 1021-1026.
89. Dali-Youcef, N.; Lagouge, M.; Froelich, S.; Koehl, C.; Schoonjans, K.; Auwerx, J. Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann. Med., 2007, 39, 335-345.
90. van Leeuwen, I.; Lain, S. Sirtuins and p53. Adv. Cancer Res., 2009, 102, 171-195.
91. Yeung, F.; Hoberg, J.E.; Ramsey, C.S.; Keller, M.D.; Jones, D.R.; Frye, R.A.; Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J., 2004, 23, 2369-2380.
92. Chen, J.; Zhou, Y.; Mueller-Steiner, S.; Chen, L.F.; Kwon, H.; Yi, S.; Mucke, L.; Gan, L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem., 2005, 280, 40364-40374.
93. Kolthur-Seetharam, U.; Dantzer, F.; McBurney, M.W.; de Murcia, G.; Sassone-Corsi, P. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle, 2006, 5, 873-7.
94. + and NADH in ischemic brain injury. Front Biosci., 2008, 13, 1141-1151.
95. Wang, L.; Zhang, L.; Chen, Z.B.; Wu, J.Y.; Zhang, X.; Xu, Y. Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1. Eur. J. Pharmacol., 2009, 609, 40-44.
96. Della-Morte, D.; Dave, K.R.; DeFazio, R.A.; Bao, Y.C.; Raval, A.P.; Perez-Pinzon, M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience, 2009, 159, 993-1002.
97. Kakefuda, K.; Fujita, Y.; Oyagi, A.; Hyakkoku, K.; Kojima, T.; Umemura, K.; Tsuruma, K.; Shimazawa, M.; Ito, M.; Nozawa, Y.; Hara, H. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem. Biophys. Res. Commun., 2009, 387, 784-788.
98. Fan, E.; Zhang, L.; Jiang, S.; Bai, Y. Beneficial effects of resveratrol on atherosclerosis. J. Med. Food, 2008, 11, 610-614.
99. Manna, S.K.; Mukhopadhyay, A.; Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 2000, 164, 6509-6519.
100. Haigis, M.C.; Sinclair, D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol., 2010, 5, 253-295.
101. Imai, S.I.; Guarente, L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol. Sci., 2010, [Epub ahead of print].
102. Guarente, L. Sirtuins in aging and disease. Cold Spring Harb. Symp. Quant. Biol., 2007, 72, 483-488.